Korify Capital
Overview
Korify Capital is a venture capital firm focused on investing in innovative companies with the potential to shape the future, particularly those in longevity, mental health, and regenerative medicine . The firm focuses on three investment strategies: Distributed development companies, enabling technologies, and domain-specific platforms .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Cambrian Bio | Oct 2021 | Series C | - |
| Gameto | Sep 2022 | Series A Extension | Co-investor |
| LEAF4Life | Dec 2022 | Series B | Co-investor |
| AERA Health | Mar 2023 | Pre Seed | Lead |
| Cleara Biotech | - | Convertible Debt | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Korify Capital based?
Korify Capital is headquartered in Basel, Basel-Stadt, Switzerland.
When was Korify Capital founded?
Korify Capital was founded in 2020.
How many portfolio companies does Korify Capital have?
Korify Capital has 7 portfolio companies in Caplight's dataset.
What are some companies in Korify Capital's portfolio?
Portfolio companies visible on Caplight include Cambrian Bio, Gameto, LEAF4Life, AERA Health, Cleara Biotech.
What was Korify Capital's most recent investment shown here?
Korify Capital's most recent investment in this portfolio sample was in AERA Health in 2023.
What sectors does Korify Capital focus on?
Korify Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Enterprise Software.
What company stages does Korify Capital focus on?
Korify Capital typically invests at the Early stage.
What is Korify Capital's AUM?
Korify Capital's assets under management are estimated between $50.0M and $100.0M.